LoL, or you just bought in more on a nothing announcment and the price has now sunk back lower to what it was.
Remember when you were arguing about how I didnt know what was happening here because I only looked at the figures.
AC8 has approx 11 million AUD in the bank.
AC8 are losing on average 2 million a quarter ( this based on the last 8 quarterlies)
Im well aware of how biotechs work, well aware of the huge cash burn with potential of no return. As Im sure you are too with holding BOT, CPH, ZLD, but AC8s going to be different right? Its pot luck here, maybe they can pull it off maybe go to nothing.
There is no way AC8 is going to end of 2022 without a capraise, mark my words. The market knows this too, they know AC8 are going to be doing a cap raise at a discounted price to the current SP.
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann Receives Positive MOC from the U.S. FDA for CPAT-01
Ann: AusCann Receives Positive MOC from the U.S. FDA for CPAT-01, page-31
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)